Sort
35,931 grants matching “parkinsons”
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
$466,950Joana M Murad · Celdara Medical, Llc · R44 · FY2023 · NS
NADPH Oxidase 2 in Parkinson's Disease Pathogenesis
$466,915Roberto Di Maio · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · NS
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading
$466,896Xiaobo Mao · Johns Hopkins University · R01 · FY2021 · AG
Neural Toxicity of Paraquat is Related to Iron Regulation in the Midbrain
$466,821Byron C Jones · University Of Tennessee Health Sci Ctr · R01 · FY2014 · ES
Transformation of the stress response into motor behavior by the external globus pallidus
$466,817Nicholas J Justice · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · MH
Transformation of the stress response into motor behavior by the external globus pallidus
$466,817Nicholas J Justice · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · MH
Transformation of the stress response into motor behavior by the external globus pallidus
$466,817Nicholas J Justice · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · MH
The Mitochondrion-STING Axis in An Early Childhood Onset Neurodegenerative Disease
$466,631Nan Yan · Ut Southwestern Medical Center · R01 · FY2022 · NS
The Mitochondrion-STING Axis in An Early Childhood Onset Neurodegenerative Disease
$466,631Nan Yan · Ut Southwestern Medical Center · R01 · FY2025 · NS
The Mitochondrion-STING Axis in An Early Childhood Onset Neurodegenerative Disease
$466,631Nan Yan · Ut Southwestern Medical Center · R01 · FY2021 · NS
The Mitochondrion-STING Axis in An Early Childhood Onset Neurodegenerative Disease
$466,631Nan Yan · Ut Southwestern Medical Center · R01 · FY2023 · NS
Quantitative mapping of molecules and release properties at nerve terminals
$466,618Timothy A Ryan · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · MH
Quantitative mapping of molecules and release properties at nerve terminals
$466,618Timothy A Ryan · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · MH
Quantitative mapping of molecules and release properties at nerve terminals
$466,618Timothy A Ryan · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · MH
Quantitative mapping of molecules and release properties at nerve terminals
$466,618Timothy A Ryan · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · MH
Optimization of ultrasound-facilitated blood-brain barrier opening
$466,553Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2014 · EB
MOLECULAR EPIDEMIOLOGY OF PARKINSON'S DISEASE
$466,541Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · ES
Structure and Function of Neurotransmitter Transporters
$466,529James Eric Gouaux · Oregon Health & Science University · R01 · FY2024 · MH
A new model for Src tyrosine kinase activation through lipid phosphatidic acid
$466,500Bradley J Stith · University Of Colorado Denver · R15 · FY2016 · GM
Elucidating the role of Adaptor Protein complex-4 in regulating axonal autophagic and lysosomal pathways
$466,491Swetha Gowrishankar · University Of Illinois At Chicago · R01 · FY2024 · AG
Modulation of Lipid Bisretinoids Clearance with Beta-Cyclodextrins
$466,458Marcelo M Nociari · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · EY
A Confocal Laser Scanning Microscope for Neuroscience Imaging Center
$466,377William E Armstrong · University Of Tennessee Health Sci Ctr · S10 · FY2010 · RR
Parkinson Disease Clinical Subtypes: Validation, Clinical Utility, and Biological Correlates
$466,371Meghan C Campbell · Washington University · R01 · FY2019 · NS
Parkinson Disease Clinical Subtypes: Validation, Clinical Utility, and Biological Correlates
$466,371Meghan C Campbell · Washington University · R01 · FY2018 · NS
Parkinson Disease Clinical Subtypes: Validation, Clinical Utility, and Biological Correlates
$466,371Meghan C Campbell · Washington University · R01 · FY2020 · NS